C erebral infarction-induced cessation of function in areas of the brain remote from, but connected to, the primary site of damage was termed "diaschisis" by von Monakow. 1 Initially, the concept of diaschisis did not include morphological changes. However, accumulating evidence has shown that histopathologic changes also occur in nonischemic remote brain regions that have synaptic connections with the primary lesion site. For example, after cerebral infarction in the middle cerebral artery (MCA) territory, neuronal death, gliosis, and axonal degeneration have been found in the ipsilateral thalamus, substantia nigra (SN), and distal pyramidal tract, all of which lie outside the MCA territory. [2] [3] [4] [5] [6] [7] This kind of secondary neurodegeneration occurs selectively in such areas several days or weeks after stroke onset, and this can be detected by neuroimaging techniques. 8 For quite a long time, the role of secondary degeneration in stroke recovery has not been well understood. Recently, emerging studies suggest that secondary degeneration is associated with neurological deficits and can predict motor outcome after stroke. 9 -15 In this review, we aimed to summarize the pathological and neuroimaging evidence of secondary neurodegeneration in the ipsilateral thalamus, SN, and pyramidal tract after MCA infarction and described its potential significance for stroke management. We searched PubMed from 1980 to September 2011, using the terms "cerebral infarction," "middle cerebral artery," "Wallerian degeneration," "anterograde degeneration," "retrograde degeneration," and "transneuronal degeneration." Further articles were identified from the references cited in those articles and through searches of our personal files. The final list of references was selected on the basis of originality and relevance to the topics covered in this review.
Evidence of Secondary Degeneration After Stroke

Postmortem Studies
Data from postmortem studies provide direct evidence of secondary neurodegeneration after focal cerebral infarction ( Figure 1) . Histopathologic examination at 4 months after MCA infarction revealed a delayed and selective decrease in the neuron density, neuropil rarefaction, and reactive astrocytosis in the ipsilateral thalamus. 2 Different from the pathological features of primary infarction, macrophages were rare in the thalamus. 2 This secondary lesion cannot be explained by insufficient blood supply, and it may reflect retrograde degeneration of the thalamocortical fibers.
The SN is another brain structure that is subjected to secondary degeneration after MCA infarction. Forno 3 reported 10 cases of slight to moderate nerve cell loss in the compact zone of the ipsilateral SN ranging from 6 months to 10 years after massive unilateral infarction of the basal ganglia. One case displayed perineuronal sprouts and paired helical filaments in the ipsilateral SN. The neuronal loss was interpreted as being mainly retrograde degeneration of the nigrostriatal fibers, the perineuronal sprouts as a reaction to partial deafferentation, and the paired helical filaments as either a retrograde or a trans-synaptic reaction. 3 Additionally, MCA infarction also causes Wallerian degeneration of the distal pyramidal tract. Buss et al 4, 5 investigated temporal changes in the Wallerian degeneration in the spinal cords of patients who died 2 days to 30 years after either cerebral infarction or traumatic spinal cord injury, and they found axonal loss, myelinolysis, and astrocytic reactions. The appearance of these pathological changes is delayed relative to the infarction, starting from the segments close to the lesion site and extending to the distal segments. For example, axonal loss and myelinolysis first appeared in the corticospinal tract of the cervical segment 2 weeks after stroke onset and then progressed to the lumbar segment at 5 weeks. 4 Similarly, no astrocytic reaction was detected in the degenerating corticospinal tract until 4 months after injury. 4, 5 Moreover, activated microglia were found in the descending corticospinal tract at a delayed stage after cerebral infarction. Human leukocyte antigen -DA-positive microglia were detected in the gray matter of the spinal cord contralateral to the infarct within 2 weeks after stroke. 6, 7 As survival time progressed from 5 weeks to 4 months, the numbers of human leukocyte antigen-DA-positive microglia decreased in the gray matter but were abundant within the contralateral corticospinal tract. Although the role of these activated microglia in Wallerian degeneration was unclear, they were believed to contribute to removal of the degenerating axons. 6, 7 Plain CT and Conventional MRI The neuroimaging features of secondary neurodegeneration have been summarized in the Table. The CT scan revealed atrophy of the thalamus and pyramidal tract at the chronic phase after massive cerebral infarction. Tamura et al 16 first reported progressive shrinkage of the ipsilateral thalamus after MCA infarction in 15 (45.5%) of the 33 patients. In the study, the thalamic area gradually decreased starting at 3 months after stroke, and marked atrophy was observed after 1 year. 16 Notably, the atrophic change seemed to be related to the size and location of the infarction. Warabi et al 17 investigated the association between shrinkage of the basis pedunculi and the site of primary damage in 89 chronic hemiplegic patients and found that the location of the basis pedunculi shrinkage was determined by the primary infarction site. These results suggest that secondary degeneration can be predicted by the location and extent of the primary ischemic lesions.
In contrast with CT, MRI is more sensitive to secondary degeneration after stroke. A hyperintense area was detected on T2-weighted spin-echo images within the ipsilateral thalamus in 14 (47%) of the 30 patients with embolic cerebral infarction. 2 Interestingly, signal abnormality on T2-weighted images varied in different nucleus of the thalamus. A hyperintense signal was detected within the dorsomedial and pulvinar nucleus at 6 weeks after cerebral infarction, whereas a hypointense signal was revealed within the ventral nuclei a few weeks after infarction. 18 Besides the thalamus, MRI also can reveal the secondary degeneration in the SN. In patients with striatal infarction, T2-weighted images revealed a hyperintense spot in the ipsilateral SN. This abnormal spot appeared after an average of 14.3 days after the stroke onset and then became less intense 3 months after onset. 19 Wallerian degeneration of the pyramidal tract displays an evolution of signal changes on T2-weighted and proton densityweighted images. Within 1 month, no abnormalities were found in the ipsilateral basis pedunculi or basis pontis. At 1 to 3 months, a hypointense band was evident in these areas. The low signal then evolved to be hyperintense and stabilized at 3 months after stroke onset. Over the course of 6 to 12 months, shrinkage of the ipsilateral basis pedunculi and basis pontis occurred. 20, 21 The temporal low signal on T2-weighted and/or proton densityweighted images may result from a transiently increased lipidprotein ratio because of myelin sheath degradation, whereas the high intensity reflected increased water content in the enlarged extracellular spaces. 20 
Diffusion-Weighted Imaging and Diffusion Tensor Imaging
In a case report study, a transitory diffusion-weighted imaging hyperintense lesion accompanied by a decreased apparent diffusion coefficient value was noted in the ipsilateral SN within 2 weeks after MCA infarction. 22 Additionally, a similar evolution of signal change also was detected in the area of pyramidal tract: a high signal on diffusion-weighted imaging and low apparent diffusion coefficient value were evident in the first 2 weeks after stroke onset and disappeared thereafter. 23, 24 More importantly, recent studies reported that diffusion-weighted imaging hyperintensity or apparent diffusion coefficient map hypointensity in the pyramidal tract was correlated with poor motor outcome, suggesting that a diffusion-weighted imaging signal abnormality in the pyramidal tract is an early predictor of motor recovery after cerebral infarction. 9 -11 In 2 longitudinal diffusion tensor imaging studies, a significant increase in mean diffusivity was noted in the ipsilateral thalamus 1 to 6 months after MCA infarction, whereas fractional anisotropy (FA) remained unchanged. 25, 26 The increased mean diffusivity is probably attributable to a progressive loss of cell membranes-the most important barriers of water movementand the lack of FA changes may be related to the absence of isolated bundles of parallel fibers within the thalamus. 25 Consistently, our study using diffusion tensor imaging and proton magnetic resonance spectroscopy revealed a decrease in Figure 1 . Secondary neurodegeneration after middle cerebral artery (MCA) infarction. Focal cerebral infarction in the MCA territory not only causes neuronal damage in the area of ischemia but also affects nonischemic regions that have synaptic connections with the primary lesion site, such as the ipsilateral thalamus, the substantia nigra (SN), and the distal pyramidal tract. Pathological changes include neuronal death, axonal degeneration, and gliosis. MCAdt, middle cerebral artery deep territory; MCAst, middle cerebral artery superficial territory; Puta, putamen; Thal, thalamus.
N-acetylaspartate concentration, a marker for neuronal and axonal integrity and function, in the ipsilateral thalamus after subcortical infarction. 29 Different from the thalamus, the pyramidal tract is composed of parallel fibers. Therefore, a marked reduction in FA values was found in the descending pyramidal tract distal to the primary infarction, accompanied by increased or unaltered mean diffusivity. 27, 28 Interestingly, decreased anisotropy was associated with motor outcome after stroke. 12, 15 Our prospective cohort studies further investigated the association between FA changes in the pyramidal tract above and below the primary infarcts and neurological deficits (Figure 2) . The results demonstrated that FA values decreased progressively over 1 to 12 weeks in the pyramidal tract, both proximally and distally to a subcortical cerebral infarct or pontine infarct. Moreover, the percent reductions in FA value were negatively correlated with the percent changes in National Institutes of Health Stroke Scale and the Fugl-Meyer scale. 13, 14 Potential Therapeutic Targets Because secondary degeneration occurs several days or weeks after stroke onset and the therapeutic time window for such lesions is not as narrow as that of the primary infarction, it is expected that the development of therapies targeting secondary degeneration would enhance brain plasticity and improve functional outcomes. In fact, secondary degeneration after MCA occlusion has been shown in experimental studies (Figure 3) , and several potential therapeutic targets have been proposed.
Apoptosis
Morphological features indicative of apoptosis, such as DNA fragmentation, nuclear condensation, and apoptotic bodies, have been observed in the ipsilateral thalamus after focal cerebral infarction in rats. 30, 31 Terminal deoxynucleotidyltransferase-mediated dUTP biotin nick end labeling is a marker of double-strand DNA damage. After MCA occulusion, terminal deoxynucleotidyltransferase-mediated dUTP biotin nick end labeling-positive cells were evident in the ipsilateral ventrobasal thalamus. 30, 31 Interestingly, the terminal deoxynucleotidyltransferase-mediated dUTP biotin nick end labeling-positive cells in the thalamus displayed concurrent apoptotic and necrotic alterations under electron microscopy. Moreover, caspase-3 activity was markedly increased in the terminal deoxynucleotidyltransferase-mediated dUTP biotin nick end labeling-positive cells. Treatment with a caspase inhibitor significantly reduced the number of terminal deoxynucleotidyltransferase-mediated dUTP biotin nick end labeling-positive cells in the ipsilateral thalamus. 30 These findings suggest that apoptosis may be involved in the secondary thalamic degeneration. In addition, the observation that antiapoptotic Bcl-2 expression was reduced in the thal- Hyperintensity on T2WI at 1 or 2 wk after stroke and becomes less intense 3 mo later 19 No abnormal intensity within 1 mo after stroke Hyperintensity in the dorsomedial and pulvinar nucleus at 6 wk after stroke 2, 18 Hypointensity 1-3 mo after stroke Hyperintensity after 3 mo 20, 21 DWI Not reported Transient hyperintensity on DWI with decreased ADC within 2 wk after stroke 22 Transient hyperintensity on DWI with decreased ADC within 2 wk after stroke 23, 24 
DTI
Increased MD values at 3 mo after stroke onset, with FA values unchanged 25, 26 Not reported Reduced FA values at both acute (1 wk) and chronic stages (several years) 12, 13, 27, 28 ADC indicates apparent diffusion coefficient; CT, computed tomography; DTI, diffusion-tensor imaging; DWI, diffusion-weighted imaging; FA, fractional anisotropy; MCA, middle cerebral artery; MD, mean diffusivity; MRI, magnetic resonance imaging; PDWI, proton density-weighted imaging; T2WI, T2-weighted imaging.
amus and that Bcl-2 overexpression in transgenic mice prevented the neuronal loss in the thalamus further supports the possible involvement of apoptosis in secondary degeneration after cerebral infarction. 32, 33 Inflammatory Reaction In humans and animals, cytokine upregulation and microglial/ astrocytic reactions have been frequently detected before or concurrently with neuronal damage at remote regions after focal cerebral infarction. A recent review of inflammation in a remote area after focal brain lesion has discussed this aspect in detail. 8 The inflammatory response seems to be an early event in secondary neurodegeneration. In the ipsilateral thalamus, tumor necrosis factor-␣ was upregulated 1 day after MCA occlusion, and the microglial/astrocytic reaction was activated after 3 days. 34 In contrast, neuronal degeneration was initiated only 4 days after MCA occlusion, and it became evident after 14 days. 34, 35 Some evidence supports the idea that the inflammatory response may contribute to neuronal damage. Osteopontin, a secretory product of activated macrophages, was reported to be protective against secondary thalamic lesions via antiinflammatory effects. 36 Additionally, astrocytic scarring in the spinal cord after cerebral infarction was believed to form an environment that is unfavorable for axonal regeneration. 4 Nevertheless, the role of the inflammatory reaction in the neuronal damage at remote regions has not been fully elucidated. It remains unclear whether the inflammatory response is merely a consequence of brain lesions.
Neurotoxic and Neuroinhibitory Factors
Neurotoxic and neuroinhibitory factors also may be involved in secondary lesions after focal cerebral infarction. Retrograde and anterograde degeneration of fibers may cause excitotoxicity in remote regions, leading to neuronal death. For example, the pars reticulata of the SN receives GABAergic inhibitory projections from the striatum and glutamatergic inputs from the subthalamic nucleus. 8 Striatal infarction may impair inhibitory afferents to the reticulata of the SN, leading to increased metabolism and neuronal death. 35 Consistent with this presumption, treatment with MK-801 (glutamate N-methyl-d-aspartate receptor antagonist) as well as YM872 (␣-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist) can reduce secondary degeneration in the reticulata of the SN after MCA occlusion. 37,38 
Zhang et al Secondary Lesions After Cerebral Infarction
Amyloid-beta (A␤), a main constituent of senile plaque in Alzheimer disease, is known to be neurotoxic. In the ipsilateral thalamus, A␤ accumulated abnormally and aggregated to plaque-like deposits for up to 9 months after MCA occlusion. 39 We investigated the association of A␤ with secondary thalamic damage and found that administration of a functional ␥-secretase inhibitor significantly reduced A␤ deposits and neuronal loss in the thalamus, suggesting that A␤ deposits may be associated with secondary thalamic damage. 40 In addition to A␤, Nogo-A, which can inhibit axonal growth, also has been shown to be upregulated within 4 weeks after MCA occlusion. 41 The elevation of Nogo-A may contribute to maintaining an environment that is hostile to axonal regeneration. Treatment with a Nogo-66 receptor antagonist NEP1-40 can block the effect of Nogo-A and lead to enhanced axonal regeneration and attenuation of neuronal degeneration. 41 
Oxidative Damage
Oxidative damage to nDNA not only contributes to neuronal damage in the primary infarction but also participates in the pathogenesis of secondary neurodegeneration in remote regions. After focal cerebral infarction, endogenous antioxidant defenses were activated at the remote regions. Increased immunoreactivity of manganese-superoxide dismutase and expression of damage-induced neuronal endopeptidase mRNA was observed in the ipsilateral thalamus after MCA occlusion in rats. 42, 43 Superoxide dismutases are known to effectively scavenge superoxide radicals and protect neurons from oxidative damage, and damage-induced neuronal endopeptidase can be upregulated in response to neuronal insult and activate superoxide dismutases. Therefore, the elevation of manganese-superoxide dismutase and damage-induced neuronal endopeptidase may reflect increased oxidative stress in the ipsilateral thalamus.
Our study in rats revealed enhanced expression of 8-hydroxy-2Ј-deoxyguanosine and decreased expression of 8-oxoguanine DNA glycosylase in the ipsilateral thalamus after MCA occlusion, indicating an imbalance between oxidative DNA damage and the base repair activity ratio. 44 Furthermore, treatment with ebselen, an antioxidant, significantly attenuated the increased 8-hydroxy-2Ј-deoxyguanosine expression, ameliorated the decreased 8-oxoguanine DNA glycosylase expression, and reduced the neuronal loss in the ipsilateral thalamus. 44 
Macroautophagy
Macroautopahgy is a lysosomal pathway for the recycling of intracellular organelles and proteins and plays multiple roles in cell homeostasis. It has been suggested that macroautophagy can promote cell survival in chronic brain diseases and can mediate cell death in acute neurological disorders, implicating the effects of macroautophagy are contextdependent. 45 We investigated the role of macroautophagy in the secondary thalamic degeneration after cerebral cortical infarction in rats and found that macroautophagy was activated in the ipsilateral thalamic cells. 46, 47 Furthermore, macroautophagic inhibitor and Beclin-1 knockdown significantly reduced the macroautophagic activation and neuronal loss, suggesting macroautophagy may act in cell death in secondary thalamic degeneration. 46, 47 To further understand the role of macroautophagy in secondary degeneration, it is necessary to investigate exactly how macroautophagy contributes to cell death and its relationship with other cell death pathways. Interestingly, there is cross-talk between macroautophagy and A␤ deposits. Inhibition of macroautophagy prevented the A␤ accumulation and, conversely, reduction of A␤ suppressed macroautophagy activation. 46, 47 Future studies are needed to elucidate the underlying mechanisms.
Future Perspectives
The findings that neuroprotective agents can reduce the secondary degeneration and associate with functional improvement in animal stroke models are appealing. However, the question we constantly face is whether these effects can be translated into the clinic. Several issues should be considered before entering into clinical trials. First, most of the experimental studies targeting secondary degeneration merely assess the histological outcomes in the remote regions. More experimental studies are needed to evaluate the functional outcomes, which are the primary measures of therapeutic efficacy in clinical trials. Second, the mechanisms involved in the development of secondary degeneration have not been fully elucidated. A better understanding of the underlying mechanisms may help to identify the appropriate therapeutic targets in clinical trials. Third, our recent study has showed there are neurogenesis and angiogenesis within the ipsilateral thalamus after focal cerebral infarction, suggesting the regeneration is coupled with the damage. 48 It also would be interesting and important to investigate the role of neurogenesis and angiogenesis in stroke recovery.
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